References and Notes
1a
Lorsbach BA.
Kurth MJ.
Chem. Rev.
1999,
99:
1549
1b
Sammelson RE.
Kurth MJ.
Chem. Rev.
2000,
101:
137
1c
Dilman AD.
Ioffe SL.
Chem. Rev.
2003,
103:
733
1d
Casiraghi G.
Zanardi F.
Appendino G.
Rassu G.
Chem. Rev.
2000,
100:
1929
1e
Luh T.-Y.
Leung M.-K.
Wong K.-T.
Chem. Rev.
2000,
100:
3187
1f
Li C.-J.
Chem. Rev.
2005,
105:
3095
1g
Fagnou K.
Lautens M.
Chem. Rev.
2003,
103:
169
1h
Svedendahl M.
Hult K.
Berglund P.
J. Am. Chem. Soc.
2005,
127:
17988
1i
Fillion E.
Carson RJ.
Trépanier VE.
Goll JM.
Remorova AA.
J. Am. Chem. Soc.
2004,
126:
15354
2a
Jørgensen M.
Lee S.
Liu X.
Wolkowski JP.
Hartwig JF.
J. Am. Chem. Soc.
2002,
124:
12557
2b
You J.
Verkade JG.
Angew. Chem. Int. Ed.
2003,
42:
5051
2c
You J.
Verkade JG.
J. Org. Chem.
2003,
68:
8003
2d
Beare NA.
Hartwig JF.
J. Org. Chem.
2002,
67:
541
2e
Stauffer SR.
Beare NA.
Stambuli JP.
Hartwig JF.
J. Am. Chem. Soc.
2001,
123:
4641
2f
Fox JM.
Huang X.
Chieffi A.
Buchwald SL.
J. Am. Chem. Soc.
2000,
122:
1360
2g
Moradi WA.
Buchwald SL.
J. Am. Chem. Soc.
2001,
123:
7996
2h
Terao Y.
Fukuoka Y.
Satoh T.
Miura M.
Nomura M.
Tetrahedron Lett.
2002,
43:
101
2i
Lloyd-Jones GC.
Angew. Chem. Int. Ed.
2002,
41:
953
2j
Kashin AN.
Mitin AV.
Beletskaya IP.
Wife R.
Tetrahedron Lett.
2002,
43:
2539
2k
Hamada T.
Chieffi A.
Åhman J.
Buchwald SL.
J. Am. Chem. Soc.
2002,
124:
1261
2l
Viciu MS.
Germaneau RF.
Nolan SP.
Org. Lett.
2002,
4:
4053
3a
Hassan J.
Sévignon M.
Gozzi C.
Schulz E.
Lemaire M.
Chem. Rev.
2002,
102:
1359
3b
Ley SV.
Thomas AW.
Angew. Chem. Int. Ed.
2003,
42:
5400
3c
Kunz K.
Scholz U.
Ganzer D.
Synlett
2003,
2428
3d
Hennessy EJ.
Buchwald SL.
Org. Lett.
2002,
4:
269
3e
Ma D.
Liu F.
Chem. Commun.
2004,
1934
3f
Zhang S.
Zhang D.
Liebeskind LS.
J. Org. Chem.
1997,
62:
2312
3g
Bates CG.
Saejueng P.
Venkataraman D.
Org. Lett.
2004,
6:
1441
3h
Jiang Y.
Wu N.
Wu H.
He M.
Synlett
2005,
2731
4a
Hurtley WRH.
J. Chem. Soc.
1929,
1870
4b
Bruggink A.
Ray SJ.
McKillop A.
Org. Synth.
1978,
58:
52
4c
Bryson TA.
Stewart JJ.
Gibson JM.
Thomas PS.
Berch JK.
Green Chem.
2003,
5:
174
4d
Bruggink A.
McKillop A.
Tetrahedron
1975,
31:
2607
4e
Lindley J.
Tetrahedron
1984,
40:
1433
4f
Shinkwin AE.
Whish WJD.
Threadgill MD.
Bioorg. Med. Chem.
1999,
7:
297
5a
Hang HC.
Drotleff E.
Elliott GI.
Ritsema TA.
Konopelski JP.
Synthesis
1999,
398
5b
Suzuki H.
Yi Q.
Inoue J.
Kusume K.
Ogawa T.
Chem. Lett.
1987,
887
5c
Suzuki H.
Kobayashi T.
Osuka A.
Chem. Lett.
1983,
589
6
Okuro K.
Furuune M.
Miura M.
Nomura M.
J. Org. Chem.
1993,
58:
7606
7a
Ma D.
Cai Q.
Xie X.
Synlett
2005,
1767
7b
Zhu W.
Ma D.
J. Org. Chem.
2005,
70:
2696
7c
Cai Q.
Zhu W.
Zhang H.
Zhang Y.
Ma D.
Synthesis
2005,
496
7d
Ma D.
Cai Q.
Zhang H.
Org. Lett.
2003,
5:
2453
7e
Ma D.
Cai Q.
Org. Lett.
2003,
5:
3799
7f
Ma D.
Cai Q.
Synlett
2004,
128
7g
Pan X.
Cai Q.
Ma D.
Org. Lett.
2004,
6:
1809
7h
Zhu W.
Ma D.
Chem. Commun.
2004,
888
7i
Zhang H.
Cai Q.
Ma D.
J. Org. Chem.
2005,
70:
5164
7j
Xie X.
Cai G.
Ma D.
Org. Lett.
2005,
7:
4693
8a
Marcoux J.-F.
Doye S.
Buchwald SL.
J. Am. Chem. Soc.
1997,
119:
10539
8b
Kiyomori A.
Marcoux JF.
Buchwald SL.
Tetrahedron Lett.
1999,
40:
2657
8c
Wolter M.
Klapars A.
Buchwald SL.
Org. Lett.
2001,
3:
3803
8d
Klapars A.
Antilla JC.
Huang X.
Buchwald SL.
J. Am. Chem. Soc.
2001,
123:
7727
8e
Antilla JC.
Buchwald SL.
Org. Lett.
2001,
3:
2077
9
Wang Z.
Bao W.
Jiang Y.
Chem. Commun.
2005,
2849
10a
Wan Z.
Jones CD.
Koenig TM.
Pu YJ.
Mitchell D.
Tetrahedron Lett.
2003,
44:
8257
10b
Willis MC.
Taylor D.
Gillmore AT.
Chem. Commun.
2003,
2222
10c
Nordmann G.
Buchwald SL.
J. Am. Chem. Soc.
2003,
125:
4978
11
Typical Procedure: A two-necked flask was charged with vinyl bromide (0.5 mmol), CuI (0.05 mmol), l-proline (0.1 mmol), and Cs2CO3 (1.0 mmol), evacuated, and backfilled with nitrogen. The activated methylene compound (1.0 mmol) and DMSO (2 g) were added under nitrogen. The flask was immersed in a pre-heated oil bath, and the reaction mixture was stirred at 90 °C until the conversion was complete (detected by TLC). The cooled mixture was purified by column chromatography on silica gel (PE-EtOAc, 10:1 to 5:1) to provide the desired product.
(
E
)-3-Styrylpentane-2,4-dione (Table
[2]
, entry 1): IR (film): 3429.1, 3062.4, 3029.7, 2927.2, 1709.1, 1600.9, 1495.2, 1450.2, 1357.4, 1204.9, 1143.7, 1025.8, 976.2, 751.0, 699.4 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.21 (6 H, s, CH3), 6.41 (1 H, d, J = 16.4 Hz, CH), 6.74 (1 H, d, J = 16.4 Hz, CH), 7.34-7.43 (5 H, m, ArH) 16.75 (1 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 24.23, 111.30, 122.73, 126.05, 127.65, 128.66, 134.16, 137.02, 191.16. MS (70 eV): m/z (%) = 209.0992 (43), 176.0828 (100). HRMS (70 eV): m/z calcd for C13H14O2, 202.0988; found: 202.0992.
(
E
)-Ethyl-2-acetyl-4-phenylbut-3-enoate (Table
[2]
, entry 2): IR (film): 3459.6, 3061.9, 3029.3, 2982.8, 2936.7, 1732.5, 1599.7, 1449.9, 1368.5, 1247.5, 1079.8, 1018.0, 757.9, 699.6 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.29 (1.2 H, t, J = 7.2 Hz, CH3), 1.35 (1.8 H, t, J = 7.2 Hz, CH3), 2.22 (1.8 H, s, CH3), 2.28 (1.2 H, s, CH3), 4.23 (0.8 H, q, J = 7.2 Hz, CH2), 4.24 (0.4 H, s, CH), 4.30 (1.2 H, q, J = 7.2 Hz, CH2), 6.42 (0.4 H, dd, J = 16.0, 9.2 Hz, CH), 6.58 (0.4 H, d, J = 16.0 Hz, CH), 6.60 (0.6 H, d, J = 16.0 Hz, CH), 6.74 (0.6 H, d, J = 16.0 Hz, CH), 7.31-7.42 (5 H, m, ArH), 13.37 (0.6 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 14.03, 14.19, 20.28, 28.45, 60.92, 61.68, 63.87, 101.28, 120.99, 121.57, 125.91, 126.56, 127.04, 128.18, 128.54, 128.60, 130.62, 135.36, 135.99, 138.03, 168.41, 172.63, 174.64, 201.38. MS (70 eV): m/z (%) = 232.1099 (84) [M+], 205.0856 (100), 190.0986 (97), 171.0440 (62). HRMS (70 eV): m/z calcd for C14H16O3: 232.1094; found: 232.1099.
(
E
)-Diethyl-2-styrylmalonate (Table
[2]
, entry 3): IR (film): 2983.3, 2938.7, 2909.6, 1732.6, 1465.2, 1449.4, 1369.3, 1258.4, 1151.3, 1033.8, 967.1, 857.8, 757.9, 692.7 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.28 (6 H, t, J = 7.2 Hz, CH3), 4.17-4.26 (5 H, m, CH2, CH), 6.42 (1 H, dd, J = 16.0, 8.8 Hz, CH), 6.59 (1 H, d, J = 16.0 Hz, CH), 7.27-7.42 (5 H, m, ArH). 13C NMR (100 MHz, CDCl3): δ = 13.96, 55.86, 61.40, 120.84, 126.56, 128.01, 128.49, 134.96, 136.04, 167.96. MS (70 eV): m/z (%) = 262.1204 (100) [M+], 190.0989 (53), 189.0911 (28). HRMS (70 eV): m/z calcd for C15H18O4: 262.1200; found: 262.1204.
(
E
)-3-(4-Chlorostyryl)pentane-2,4-dione (Table
[2]
, entry 5): IR (film): 3055.4, 2913.6, 1443.6, 1071.7, 748.8, 692.1 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.22 (6 H, s, CH3), 6.36 (1 H, d, J = 16.4 Hz, CH), 6.72 (1 H, d, J = 16.4 Hz, CH), 7.30-7.36 (4 H, m, ArH) 16.78 (1 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 24.27, 111.12, 123.38, 127.23, 128.78, 132.74, 133.22, 135.51, 191.20. MS: m/z (%) = 236.0601 (100) [M+], 238.0575 (35) [M+ + 2], 221.0365 (30). HRMS (70 eV): m/z calcd for C13H13ClO2: 236.0599; found: 236.0601.
(
E
)-Ethyl-2-acetyl-4-(4-chlorophenyl)but-3-enoate (Table
[2]
, entry 6): IR (film): 3471.5, 2982.2, 2929.3, 1722.1, 1592.1, 1491.8, 1368.8, 1247.0, 1092.0, 1013.7, 974.4, 828.9 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.30 (1.2 H, t, J = 7.2 Hz, CH3), 1.36 (1.8 H, t, J = 7.2 Hz, CH3), 2.22 (1.8 H, s, CH3), 2.29 (1.2 H, s, CH3), 4.24 (0.8 H, q, J = 7.2 Hz, CH2), 4.25 (0.4 H, s, CH), 4.30 (1.2 H, q, J = 7.2 Hz, CH2), 6.40 (0.4 H, dd, J = 16.0, 8.8 Hz, CH), 6.52 (0.4 H, d, J = 16.0 Hz, CH), 6.56 (0.6 H, d, J = 16.0 Hz, CH), 6.71 (0.6 H, d, J = 16.0 Hz, CH), 7.27-7.34 (4 H, m, ArH), 13.41 (0.6 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 14.04, 14.22, 20.32, 28.56, 61.02, 61.81, 63.72, 76.61, 101.10, 121.67, 122.15, 127.06, 127.77, 128.66, 128.79, 129.09, 132.50, 134.07, 134.48, 136.58, 168.27, 172.53, 175.02, 201.13. MS (70 eV): m/z (%) = 216.1146 (100) [M+], 268.0679 (38) [M+ + 2], 240.0554 (40), 224.0598 (80), 220.0288 (74), 207.0022 (42), 205.0052 (98). HRMS (70 eV): m/z calcd for C14H15ClO3: 266.0704; found: 216.1146.
(
E
)-Diethyl-2-(4-chlorostyryl)malonate (Table
[2]
, entry 7): IR (film): 2983.7, 2934.6, 1732.7, 1492.2, 1465.7, 1446.6, 1369.5, 1256.7, 1151.2, 1094.7, 1035.1, 968.7, 821.9 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.29 (6 H, t, J = 7.2 Hz, CH3), 4.16-4.26 (5 H, m, CH2, CH), 6.40 (1 H, dd, J = 16.0, 8.8 Hz, CH), 6.55 (1 H, d, J = 16.0 Hz, CH), 7.28-7.35 (4 H, m, ArH). 13C NMR (100 MHz, CDCl3): δ = 13.89, 55.66, 61.33, 121.49, 127.71, 128.59, 133.65, 134.50, 167.73. MS (70 eV): m/z (%) = 296.0818 (100) [M+], 298.0784 (32) [M+ + 2], 224.0600(80), 223.0522 (35), 178.0181 (40).
HRMS (70 eV): m/z calcd for C15H17ClO4: 296.0810; found: 296.0818.
(
E
)-3-(4-Methylstyryl)pentane-2,4-dione (Table
[2]
, entry 8): IR (film): 3055.4, 2913.6, 1443.6, 1071.7, 748.8, 692.1 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.21 (6 H, s, CH3), 2.36 (3 H, s, CH3), 6.38 (1 H, d, J = 16.0 Hz, CH), 6.68 (1 H, d, J = 16.0 Hz, CH), 7.16 (2 H, d, J = 8.0 Hz, ArH), 7.16 (2 H, d, J = 8.0 Hz, ArH), 16.71 (1 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 21.18, 24.23, 111.40, 121.72, 125.99, 129.36, 134.17, 134.24, 137.61, 191.13. MS (70 eV): m/z (%) = 216.1148 (100) [M+], 201.0912 (61). HRMS (70 eV): m/z calcd for C14H16O3: 216.1145; found: 216.1148.
(
E
)-Ethyl-2-acetyl-4-
p-
tolylbut-3-enoate (Table
[2]
, entry 9): IR (film): 3459.1, 2981.7, 2923.5, 2868.0, 1721.8, 1639.5, 1604.2, 1513.6, 1369.4, 1245.6, 1061.4, 1019.3, 968.6, 860.4, 817.5 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.29 (1.2 H, t, J = 7.2 Hz, CH3), 1.34 (1.8 H, t, J = 7.2 Hz, CH3), 2.21 (1.8 H, s, CH3), 2.27 (1.2 H, s, CH3), 2.34 (3 H, s, CH3), 4.23 (0.8 H, q, J = 7.2 Hz, CH2), 4.24 (0.3 H, s, CH), 4.28 (1.2 H, q, J = 7.2 Hz, CH2), 6.36 (0.4 H, dd, J = 16.0, 8.8 Hz, CH), 6.54 (0.4 H, d, J = 16.0 Hz, CH), 6.55 (0.6 H, d, J = 16.0 Hz, CH), 6.68 (0.6 H, d, J = 16.0 Hz, CH), 7.13 (2 H, d, J = 8.0 Hz, ArH), 7.29-7.31 (2 H, m, ArH), 13.34 (0.6 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 14.02, 14.19, 20.23, 21.10, 21.17, 28.38, 60.85, 61.61, 63.91, 101.33, 119.90, 120.58, 125.82, 126.46, 129.22, 129.27, 130.66, 133.24, 135.22, 135.25, 136.85, 138.10, 168.51, 172.67, 174.32, 201.51. MS (70 eV): m/z (%) = 246.1254 (72) [M+], 204.1145 (38), 200.0832 (77), 185.0596 (100), 158.0727 (27). HRMS (70 eV): m/z calcd for C15H18O3: 246.1250; found: 246.1254.
(
E
)-Diethyl-2-(4-methylstyryl)malonate (Table
[2]
, entry 10): IR (film): 2982.2, 2937.9, 1732.6, 1513.8, 1463.9, 1446.3, 1368.5, 1293.0, 1257.3, 1177.2, 1096.2, 1032.1, 968.5, 862.0, 812.0 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.28 (6 H, t, J = 7.2 Hz, CH3), 2.33 (3 H, s, CH3), 4.16 (1 H, d, J = 9.2 Hz, CH), 4.23 (4 H, q, J = 7.2 Hz, CH2), 6.42 (1 H, dd, J = 16.0, 9.2 Hz, CH), 6.55 (1 H, d, J = 16.0 Hz, CH), 7.13 (2 H, d, J = 8.0 Hz, ArH), 7.31 (2 H, d, J = 8.0 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ = 14.01, 21.19, 55.94, 61.73, 119.79, 126.50, 129.22, 133.31, 134.89, 137.95, 168.12. MS (70 eV): m/z (%) =(100) [M+], 204.1147 (26), 203.1071 (28), 157.0647 (21), 129.0698 (51). HRMS (70 eV): m/z calcd for C16H20O4: 276.1356; found: 276.1363.
(
E
)-3-(4-Methoxystyryl)pentane-2,4-dione (Table
[2]
, entry 11): IR (film): 3055.4, 2913.6, 1443.6, 1071.7, 748.8, 692.1 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.21 (6 H, s, CH3), 2.96 (3 H, s, CH3), 6.35 (1 H, d, J = 16.0 Hz, CH), 6.59 (1 H, d, J = 16.0 Hz, CH), 6.89-6.91 (2 H, m, ArH), 7.35-7.37 (2 H, m, ArH), 16.68 (1 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 24.24, 55.34, 111.47, 114.14, 120.57, 127.29, 130.23, 133.88, 140.17, 191.10. MS (70 eV): m/z (%) = 232.1099 (100) [M+], 204.0782 (63), 133.0648 (37). HRMS (70 eV): m/z calcd for C14H16O3: 232.1094; found: 232.1099.
(
E
)-3-(1-Phenylprop-1-en-2-yl)pentane-2,4-dione (Table
[2]
, entry 13): IR (film): 3055.4, 2913.6, 1443.6, 1071.7, 748.8, 692.1 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.99 (2 H, s, CH3), 2.05 (3 H, d, J = 1.2 Hz, CH3), 2.13 (4 H, s, CH3), 6.42 (0.65 H, s, CH), 6.52 (0.35 H, s, CH), 7.18-7.40 (5 H, m, ArH), 16.40 (0.65 H, s, OH), 16.50 (0.35 H, s, OH). 13C NMR (100 MHz, CDCl3): δ = 20.31, 22.84, 23.17, 27.05, 113.13, 118.18, 126.83, 126.92, 127.73, 128.25, 128.45, 128.64, 131.01, 132.60, 133.04, 133.46, 137.03, 137.34, 189.87, 190.14. MS (70 eV): m/z (%) = 216.1146 (100) [M+], 201.0912 (87), 173.0961 (25). HRMS (70 eV): m/z calcd for C14H16O2: 216.1145; found: 216.1146.